Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea

Medical Science Monitor

Volumn 14, Issue 9, 2008, Pages

  Tkacova, Ruzena ^a   Dorkova, Zuzana ^a   Molcanyiova, Angela ^b   Radikova, Zofia ^c   Klimes, Iwar ^c   Tkac, Ivan ^a  

^a L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^b LABMED   (Slovakia)

^c INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

Insulin resistance; Novel risk factors; Obesity; Sleep apnea

Indexed keywords

APOLIPOPROTEIN B; FIBRINOGEN; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OBESITY; RISK ASSESSMENT; RISK FACTOR; SLEEP APNEA SYNDROME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 52249091142     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report on the National Cholesterol Education Program (NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 2002; 106: 3143-21
2. Nieto FJ, Young TB, Lind BK et al: Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA, 2000; 283: 1829-36
3. Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med, 2000; 342: 1378-84
4. Grote L, Hedner J, Peter JH: Mean blood pressure, pulse pressure and grade of hypertension in untreated hypertensive patients with sleep-related breathing disorder. J Hypertens, 2001; 19: 683-90
5. Arzt M, Young T, Finn L et al: Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med, 2005; 172: 1447-51
6. Peker Y, Hedner J, Norum J et al: Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med, 2002; 166: 159-65
7. Grundy SM, Cleeman JI, Daniels SR et al: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 2005; 112: 2735-52
8. Punjabi NM, Polotsky VY: Disorders of glucose metabolism in sleep apnea. J Appl Physiol, 2005; 99: 1998-2007
9. Lam JC, Lam B, Lam CL et al: Obstructive sleep apnea and the metabolic syndrome in community/based Chinese adults in Hong Kong. Respir Med, 2006; 100: 980-87
10. Sasanabe R, Banno K, Otake K et al: Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome. Hypertens Res, 2006; 29: 315-22
11. Ip MS, Lam B, Ng MM et al: Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med, 2002; 165: 670-76
12. Punjabi NM, Shahar E, Redline S et al: Sleep-disordered breathing, glucose intolerance, and insulin resistance. The Sleep Heart Health Study. Amer J Epidemiol, 2004; 160: 521-30
13. Harsch IA, Hahn EG, Kontourek PC: Insulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome. Med Sci Monit, 2005; 11(3): RA70-75
14. Tripathi BK, Srivastava AK. Diabetes mellitus: complications and therapeutics. Med Sci Monit, 2006; 12(7): RA130-47
15. Millman RP, Carlisle CC, McGravey ST et al: Body fat distribution and sleep apnea severity in women. Chest, 1995; 107: 362-66
16. Somers VK, Dyken ME, Clary MP, Abboud FM: Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest, 1995; 96: 1897-904
17. Polotsky VY, Li J, Punjabi NM et al: Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol, 2003; 552: 253-64
18. Rechtschaffen A, Kales A: A manual of standardized terminology, techniques and scoring systems for sleep stages of human subjects. Los Angeles, CA: UCLA Brain Information Service/Brain Research Institute, 1968
19. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation, Brussels, 2005
20. Matthews DR, Hosker JP, Rudenski AS et al: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28: 412-19
21. Alberti KGMM, Zimmet PZ, for the WHO Consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med, 1998; 15: 539-53
22. Radikova Z, Koska J, Huckova M et al: Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes, 2006; 114: 249-56
23. Marin JM, Carrizo SJ, Vicente E, Agusti AG: Long-term cardiovascular outcomes in men with obstructive sleep apnea-hypopnea with or without treatment with continuous positive airway pressure: an observational study. Lancet, 2005; 365: 1046-53
24. Tkacova R, Rankin F, Fitzgerald FS et al: Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation, 1998; 98: 2269-75
25. Leung RS, Bradley TD: Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med, 2001; 164: 2147-65
26. Tkacova R, Dajani H, Rankin F et al: Continuous positive airway pressure improves nocturnal baroreflox sensitivity in patients with heart failure and obstructive sleep apnea. J Hypertension, 2000; 18: 1257-62
27. Bonsignore MR, Parati G, Insalaco G et al: Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP. Eur Respir J, 2006; 27: 128-35
28. Yokoe T, Minoguchi K, Matsuo H et al: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation, 2003; 107: 1129-34
29. Ip MS, Tse HF, Lam B et al: Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med, 2004; 169: 348-53
30. Barter PJ, Ballantyne CM, Carmena R et al: Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med, 2006; 259: 247-58
31. Paramo JA, Beloqui O, Roncal C et al: Validation of plasma fibrinogen as a marker of carotid atherosclerosis in subjects free of clinical cardiovascular disease. Haematologica, 2004; 89: 1226-31
32. Buchner NJ, Sanner BM, Borgel J, Rump LC: CPAP treatment of mild to moderate OSAS reduces cardiovascular risk. Am J Respir Crit Care Med, 2007. doi: 10.1164/rccm.200611-1588OC
33. Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling. Diabetes Care, 2004; 27: 1487-95